1. Home
  2. BEP vs KRYS Comparison

BEP vs KRYS Comparison

Compare BEP & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Brookfield Renewable Partners L.P.

BEP

Brookfield Renewable Partners L.P.

HOLD

Current Price

$34.30

Market Cap

9.4B

Sector

Utilities

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$262.91

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BEP
KRYS
Founded
1999
2015
Country
Canada
United States
Employees
5870
N/A
Industry
Electric Utilities: Central
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.4B
7.8B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
BEP
KRYS
Price
$34.30
$262.91
Analyst Decision
Buy
Strong Buy
Analyst Count
10
11
Target Price
$34.70
$297.60
AVG Volume (30 Days)
862.4K
218.5K
Earning Date
05-01-2026
05-05-2026
Dividend Yield
4.60%
N/A
EPS Growth
N/A
128.00
EPS
N/A
6.84
Revenue
N/A
$389,130,000.00
Revenue This Year
$14.36
$39.88
Revenue Next Year
N/A
$34.38
P/E Ratio
N/A
$38.63
Revenue Growth
N/A
33.94
52 Week Low
$20.84
$123.03
52 Week High
$34.05
$298.30

Technical Indicators

Market Signals
Indicator
BEP
KRYS
Relative Strength Index (RSI) 68.42 55.53
Support Level $29.65 $255.65
Resistance Level N/A $293.60
Average True Range (ATR) 1.02 9.46
MACD 0.23 2.13
Stochastic Oscillator 98.83 73.51

Price Performance

Historical Comparison
BEP
KRYS

About BEP Brookfield Renewable Partners L.P.

Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: